Pfizer Independent Medical Education
Request for Proposals (RFP)
Acquired Aplastic Anemia: Educational
programs to upskill hematologists & primarycare physicians with current best practices
Competitive Grant Program –Pfizer Internal Review Process

Overview
This competitive grant program has two main objectives. Firstly, toincrease the knowledge of hematologists, who are not experts in thefield of acquired aplastic anemia, in the diagnosis and management of
this rare disease, which affects 2-6 new patients per million population
annually.
Secondly, to increase the knowledge of primary care physicians about
this disease to help determine the clinical signs and laboratory
parameters that should influence the decision to refer the patient to an
expert center for definitive diagnosis and treatment.
The fast and accurate diagnosis allowing immediate implementation of
appropriate treatment is a key factor influencing patients’ outcomes ofthis potentially life-threatening disease.

Geographic Scope
Global, excluding United States

Project Types and Area of Interest
Potential applicants are encouraged to identify and consider
educational needs, barriers and gaps in acquired aplastic anemia(AAA) related to complex differential diagnosis, current treatment
standards based on disease severity, comorbidities, patient age, andavailability of hematopoietic stem cell donors. This may include:•

Early identification and diagnosis of AAA patients•

Streamlining the process of referral and flow of AAA patientsto specialized, expert medical centers•

Current standards of AAA treatment and patient monitoring•

Clinical management of special patient subpopulations especially the elderly population > 65 years

Key Milestones•

Application submission deadline: August 1, 2023•

Anticipated decision notification date: September 1, 2023•

Anticipated project start date: December 2023

Funding Range and Project Length
Individual projects requesting up to $50,000 will be considered.
Pfizer anticipates supporting up to 2 projects.

I. Eligibility
Geographic Scope:•Global, excluding United States

Applicant Eligibility Criteria••

Only organizations are eligible to receive grants, not individuals or medical practice groups.
The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools;
healthcare institutions (both large and small); professional associations and medical societies; medicaleducation companies; and other entities with a mission related to healthcare professional education
and/or healthcare improvement.
• If the project involves multiple departments within an institution and/or between different institutions /organizations / associations. All institutions must have a relevant role and the requesting organizationmust have a key role in the project.

II. Requirements
Date RFP Issued•

June 26, 2023

Clinical Area•

Aplastic Anemia

General Area of Interest for this RFP:
•Potential applicants are encouraged to identify and consider educational needs, barriers and gaps inacquired aplastic anemia (AAA) related to complex differential diagnosis, current treatment standards
based on disease severity, comorbidities, patient age, and availability of hematopoietic stem cell
donors. This may include:• Early identification and diagnosis of AAA patients• Streamlining the process of referral and flow of AAA patients to specialized, expert medicalcenters• Current standards of AAA treatment and patient monitoring• Clinical management of special patient subpopulations - especially the elderly population > 65
years
It is not our intent to support clinical research projects. Projects evaluating the efficacy of therapeuticor diagnostic agents will not be considered.

Target Audience•Hematologists who are not experts in AA, general practitioners of various specialties

Expected Approximate Monetary Range of Grant Applications:•Individual projects requesting up to $50,000 USD will be considered. Pfizer anticipates supporting up
to 2 projects.

2Key Dates:•••••

RFP release date: June 26, 2023
Grant Application due date: August 1, 2023Please note the deadline is 23:59 Eastern Standard Time (e.g., New York, GMT -5).
Anticipated Grant Award Notification Date: September 1, 2023
Grants will be distributed following a fully executed agreement. The agreement is expected to besigned by both parties within 2023 and without change.
Anticipated Project Start: December 2023

How to Submit:
Note: Please read this section carefully since applications submitted not following these instructions will
not be accepted and will be cancelled• Please go to www.cybergrants.com/pfizer/knowledge and sign in. First-time users should click “Createyour password”. [Note: there are individual portals for each grant application type. Please be sure to use theURL above.]
••

•

•

Click the “Start A New Knowledge Gap Application" button.
In the application:• For the question “What type of request are you submitting?” select Response to a Request for
Proposal (RFP)• For the question “Are you replying to a Request for Proposal (RFP) as part of the Competitive
Grant Program?” select Yes• Select the following Competitive Grant Program Name: 2023 HOS Global Aplastic AnemiaIME• Select the following Primary Area of Interest: Aplastic Anemia
Requirements for submission:
Complete all required sections of the online application and upload your project proposal (seeAppendix) in the General RFP Submission field.
If you encounter any technical difficulties with the website, please click the “Technical Questions” linkat the bottom of the page.
IMPORTANT: Be advised applications submitted after the due date will not be reviewed.

Questions:•If you have questions regarding this RFP, please direct them in writing to the Grant Officer, Jessica
Romano (Jessica.Romano@pfizer.com), with the subject line “Acquired Aplastic Anemia IME RFP
June 2023.”

Grant Agreements:••••

If your grant is approved, your institution will be required to enter into a written grant agreement withPfizer. Please click here to view the core terms of the agreement.
Pfizer has drafted the terms of these agreements to be balanced and reasonable and to further thegoals of both parties. Negotiating grant agreements requires significant resources, so please ensurethat your institution (including your legal department) is able and willing to abide by these terms before
proceeding with submission of your application as they will need to be accepted in their entirety.
This RFP is supported by Pfizer Inc. and, if approved, payment will be sent from the United States.
Payment will only be made to requesting Institution.

3

Review and Approval Process•

Grant requests received in response to a general RFP are reviewed by Pfizer to make final grant
decisions.

Mechanism by which Applicants will be Notified:••

All applicants will be notified via email by the dates noted above.
Applicants may be asked for additional clarification during the review period.

About Pfizer Global Medical Grants
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives(e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical
need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP)
that provides detail regarding a general area of interest, sets timelines for review and approval, and uses
an internal Pfizer review process to make final grant decisions. Organizations are invited to submit anapplication addressing the knowledge gaps as outlined in the specific RFP.
For all independent medical education grants, the grant requester (and ultimately the grantee) is
responsible for the design, implementation, and conduct of the independent initiative supported by thegrant. Pfizer must not be involved in any aspect of project development, nor the conduct of theindependent education program.

4Appendix
General RFP Submission Requirements
Applications will be accepted via the online portal listed in the How to Submit section. ProjectProposals should be single-spaced using Calibri 12-point font and 1-inch margins. Note there is a
15-page limit exclusive of references. When uploading your Project Proposal please ensure it
addresses the following sections:
Goals and Objectives••

Briefly state the overall goal of the project.
List the objectives you plan to meet with your project, in terms of learning and expected outcomes.

Needs Assessment for the Project•

Include a description of your organization’s needs assessment for this proposed project which may
include a quantitative baseline data summary, initial metrics, or a project starting point (please cite dataon gap analyses or relevant patient-level data that informs the stated objectives) in your target area.

Target Audience•

Describe the primary audience(s) targeted for this project. Indicate whom you believe will directly benefit
from the project outcomes. Describe the overall population size as well as the size of your sample
population.

Project Design and Methods•

Describe the planned project, the educational approach, and the way the planned methods address theestablished need.

Innovation•Explain what measures you have taken to assure that this project is original and does not duplicate
other projects or materials already developed. Describe how this project builds upon existing work, pilot
projects, or ongoing projects developed either by your institution or other institutions.

Evaluation and Outcomes•

In terms of the metrics used for the needs assessment, describe how your organization will determine if
the gap was addressed for the target group. Identify the sources of data your organization anticipatesusing to make the determination. Describe how your organization is expected to collect and analyze thedata. Explain the method used to control for other factors outside this project (e.g., use of a control groupor comparison with baseline data). Quantify the amount of change expected from this project in terms thetarget audience. Describe how your organization will determine if the target audience was fully engaged
in the project.

Dissemination Plan•

Describe how the project may have extended benefit beyond the grant. Will the teaching materials be
made available to others to use? Will there be tools or resources that are made publicly availablebeyond the initial project. Describe how the project outcomes might be broadly disseminated.

Anticipated Project Timeline•

Provide an anticipated timeline for your project including project start/end dates.

5Additional Information•If there is any additional information you feel Pfizer should be aware of concerning the importance of thisproject, please summarize here

Organization Detail•

Describe the attributes of the institutions / organizations / associations that will support and facilitate theexecution of the project and the leadership of the proposed project. Articulate the specific role of eachpartner in the proposed project.

Budget Detail•••

Please include a budget narrative that describes in greater detail the line items specified in the budget
submitted within the application.
Please submit the budget in USD.
While estimating your budget please keep the following items in mind:• Independent Medical Education Grants awarded by GMG cannot be used to purchase therapeutic
assets (prescription or non-prescription).
• Overhead rates of up to 28% of the total proposed project budget may be supported by Pfizer.
Please click here for details.

6